
New Treatments and a Turning Point in Fatty Liver Disease Care with Dr. Meena Bansal
4/18/2026
0:00
9:40
In this episode, Meena Bansal, MD, FAASLD - System Chief, Division of Liver Diseases Director, MASH/NASH Center of Excellence, Icahn School of Medicine at Mount Sinai, discusses newly approved therapies for MASH and the growing impact of GLP-1 medications. She also shares insights on personalized treatment, early intervention, and the future of liver disease care.
More episodes from "Becker’s Healthcare Podcast"



Don't miss an episode of “Becker’s Healthcare Podcast” and subscribe to it in the GetPodcast app.








